Sentences with phrase «epipen pricing»

There is much outrage over the increase in EpiPen pricing from the internet as well as from the patients that need the life - saving medication.

David Carlucci wants to allow the state Attorney General to have oversight over EpiPen pricing

Mylan has defended its EpiPen pricing by pointing to patient assistance programs and coupons that reduce the device's cost.

One concern among analysts is how fallout over EpiPen pricing will affect Mylan's roughly $ 1 billion in annual sales of the device.

Congress seems to think that a trove of documents including anything prepared for the company's board having to do with the EpiPen, Mylan's tax rate, profits connected to the EpiPen, manufacturer contracts related to the EpiPen, anything related to EpiPen pricing in the Netherlands, and anything having to do with a generic EpiPen could help answer that question.

And despite the fact that Mylan raised EpiPen prices roughly 30 % in 2015 while prescription volume also grew 7 %, the company's revenue on the drug actually fell slightly, as the other players took even bigger cuts, according to Raffat.

Since late August, when the EpiPen price increases came into the spotlight, Mylan shares have fallen about 15 %.

UPDATE: On 9/21/16, the House Oversight Committee grilled Mylan and the FDA in a hearing on the EpiPen price hike.

Democratic Missouri U.S. Sen. Claire McCaskill said she expects Congress to hold hearings on the EpiPen price increases.

Also at noon, parents, EpiPen users and activists call out hedge fund manager John Paulson for what they say is his role with the EpiPen price «gauging scandal» and his donations to Trump, 1251 6th Ave., Manhattan.

The Hedge Clippers, an offshoot of the Occupy Wall Street movement, spent their Tuesday morning outside billionaire investor John Paulson's Sixth Avenue office in Midtown, protesting against the EpiPen price - gouging and his ties to the company.

Not exact matches

Rajiv Malik, president and executive director at EpiPen maker Mylan (essentially the company's number two exec), has been named in a wide - ranging civil suit alleging drug price collusion by numerous prominent generic drug makers.

The PR fiasco forced the company to buttress its own patient assistance and rebate programs for the EpiPen and to introduce an authorized generic version of the device at half the price.

But the Adrenaclick generic that is now available at some 9,600 retail CVS pharmacies is still a third of new the generic EpiPen's price.

Mylan drew major flak last year after news broke that it had steadily increased the list price for an EpiPen two - pack from about $ 100 to more than $ 600 in less than a decade.

As lawmakers and the public scrutinize dramatic price increases for other old drugs — most recently with the Mylan - owned EpiPen, which saw its cost go up by 500 % in the past nine years — the next flash point may be insulin, a drug both ubiquitous and complicated.

To make a somewhat long story short, when Mylan raised the price of the EpiPen, they went from a company quelling fear to a company instilling fear.

Through all that, the price of an EpiPen has not been lowered one cent.

That is, in part, because the price of EpiPen is tied to Mylan's stock performance, and Mylan's stock performance is tied to executive compensation.

Mylan came under fire in August when it raised the price of the EpiPen, a lifesaving allergy drug, to $ 608 for a two - pack.

Last year's scandal over Mylan's 500 % price hike of the EpiPen, a potentially lifesaving allergy treatment, tarnished Bresch's reputation, but it didn't hurt her business as much as some expected.

Noting that the actual rebate should have been at least 10 percentage points higher, Wyden and Pallone said, «Today's letter is more evidence that while Mylan irresponsibly raised the price of EpiPen, they were also bilking taxpayers out of millions of dollars.»

In a CNBC interview in August, Bresch blamed this complexity and the middlemen that are able to profit from it for EpiPen's price hikes.

Rep. Jason Chaffetz, a Utah Republican, and Rep. Elijah Cummings, a Maryland Democrat, have sent the maker of the EpiPen a letter requesting additional documents clarifying the company's pricing structure.

Mylan, one of the 10 most heavily weighted stocks in the ETF, traded more than 1.5 percent higher despite recent political pressure over the stark price increases of its life - saving EpiPen device.

In Canada, a single EpiPen can be bought for $ 100, while the UK National Health Service price for a single dose is closer to $ 38.

Besides, if Mylan were to actually reduce the price of EpiPen, it would have ramifications other than just lowering what individuals pay for the drug.

Her company is best known for jacking up the price of life - saving EpiPen anti-allergy medication, but it also manufactures naloxone, a drug meant to treat opioid over-doses.

Nor did Mylan pledge to refrain from raising the price of EpiPen further, something it has already been exploring since the product's main competitor Auvi - Q went off the market last year.

Future tax credits could prove valuable to Mylan, which has seen sales of its flagship EpiPen allergy treatment sag after consumer outrage over the allergy treatment's $ 600 list price.

«Here's the perverse thing: Had we reduced the list price, I couldn't ensure that everyone who needs an EpiPen gets one,» Mylan CEO Heather Bresch told CNBC Thursday.

That means patients who were paying EpiPen's full $ 608 list price (for a package of two) can now get the epinephrine injection device, which is used to treat a potentially fatal allergic reaction known as anaphylaxis, for about half as much.

Even after the outrage the drug faced, the price of the branded EpiPen hasn't changed, Duhigg noted on a recent trip to the pharmacy, though the company did introduce a generic that has a list price of $ 300.

According to filings, Coury made roughly $ 98 million in 2016, the same year in which the company faced criticism for the price of the EpiPen and the stock fell by almost 30 %, according to company filings.

Mylan's (myl) EpiPen's price has ballooned about 400 % since 2008, rising from about a $ 100 list price to $ 500 today (many patients are offered a $ 100 coupon for the injecting device, but it's often not enough to cover costs for American families, especially those who have health insurance with high deductibles).

The generic pharmaceutical company came into the spotlight in August 2016 for raising the price of the EpiPen to $ 608.61 from $ 93.88 over the past decade.

That's just one reason it's better for Mylan to offer a rebate instead of just slashing the price of EpiPen.

Those middlemen are by no means starving: Mylan revealed on Thursday that it wasn't pocketing the full $ 608 EpiPen wholesale price in the first place, but only $ 274 per prescription, with the remaining $ 334 split between the other parties.

Mylan is already facing competition from a number of companies ever since the backlash to its massive price hike on the EpiPen.

A test for the shares looms on Wednesday, when Mylan CEO Heather Bresch testifies before the U.S. House of Representatives Oversight Committee over price increases of EpiPen, an auto - injector of allergy medicine.

Mylan said last month that it would introduce the first generic version of EpiPen for $ 300, half the price of the branded product, as it tries to quell the backlash.

Shares of Mylan (myl) are trading at historically low valuations as the company's chief executive officer is set to face a congressional grilling on Wednesday over the price of its EpiPen emergency allergy treatment.

After all, Mylan acquired the EpiPen from another company, and while Bresch insists that significant improvements have been made to the epinephrine - delivering product itself, she also admitted on Thursday that a big part of the price increase rationale was to fund marketing and awareness efforts for the device.

Mylan CEO Heather Bresch trekked to the House of Representatives on Wednesday to testify about her company's controversial price hike for the EpiPen.

Clinton went on to reiterate her position that drug price hikes should be linked with better patient outcomes and demonstrated improvements in value, and demanded that Mylan «immediately reduce the price of EpiPens.»

On Wednesday, the Senate Special Committee on Aging, which has investigated price increases by Valeant (vrx) and other drugmakers, sent its own letter to Bresch demanding information about the EpiPen's pricing and market share since 2007.

In the first year Mylan owned EpiPen, its price increased nearly 5 %, to about $ 99 for a set of two EpiPens.

And the EpiPen controversy is drawing comments from some high - profile figures, including Hillary Clinton and Martin Shkreli himself, who tweeted that he thought the EpiPen's price should even be higher.

While the drug maker has responded to the massive backlash over its extravagant price increase on the device by boosting its patient assistance programs and introducing an authorized generic EpiPen version at half the cost, CVS» topline price will still be significantly cheaper.

Pharma giant Mylan's (myl) controversial price hike for the life - saving EpiPen device drew a sharp rebuke from Democratic presidential contender Hillary Clinton on Wednesday.